CASE STUDY: Myriad stands alone

Nature Biotechnology

Volumn 32, Issue 7, 2014, Pages 620-

  Sherkow, Jacob S ^a   Scott, Christopher ^b  

^a NEW YORK LAW SCHOOL   (United States)

^b Dept of Nature Biotechnology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COURT; GENE MUTATION; GENE SEQUENCE; GENE TECHNOLOGY; GENETIC SCREENING; GENETIC VARIABILITY; GOVERNMENT REGULATION; HUMAN; LAW SUIT; MOLECULAR DIAGNOSIS; MOLECULAR DIAGNOSTICS; MOLECULAR GENETICS; MULTIGENE FAMILY; MYRIAD GENETICS; NOTE; PATENT; PRIORITY JOURNAL; SEQUENCE ANALYSIS; ARTICLE; BIOTECHNOLOGY; ECONOMIC ASPECT; ECONOMICS; LEGAL ASPECT; ORGANIZATION AND MANAGEMENT; UNITED STATES;

BIOTECHNOLOGY; ECONOMIC COMPETITION; GENETIC TESTING; OWNERSHIP; PATENTS AS TOPIC; UNITED STATES;

EID: 84904006089     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2944     Document Type: Note

References (0)